LifeStance Health Group, Inc. $LFST Holdings Increased by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. increased its stake in LifeStance Health Group, boosting holdings by 5.0% with a total of 11,221,237 shares valued at approximately $74.7 million.
• Multiple institutional investors, including R Squared Ltd and US Bancorp DE, have significantly raised their stakes in LifeStance Health Group, contributing to a total of 85.50% institutional ownership.
• Analysts project growth for LifeStance Health Group, with UBS Group raising the target price from $8.50 to $9.00 and a general consensus rating of "Moderate Buy."

Vanguard Group Inc. grew its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 5.0% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,221,237 shares of the company's stock after acquiring an additional 531,841 shares during the period. Vanguard Group Inc. owned about 2.89% of LifeStance Health Group worth $74,733,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Parcion Private Wealth LLC acquired a new stake in shares of LifeStance Health Group in the 1st quarter worth $15,670,000. Janus Henderson Group PLC boosted its stake in shares of LifeStance Health Group by 51.4% during the 4th quarter. Janus Henderson Group PLC now owns 59,500 shares of the company's stock worth $439,000 after acquiring an additional 20,200 shares in the last quarter. Northern Trust Corp boosted its stake in shares of LifeStance Health Group by 11.7% during the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company's stock worth $11,731,000 after acquiring an additional 166,731 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of LifeStance Health Group by 2,599.0% during the 1st quarter. Victory Capital Management Inc. now owns 370,598 shares of the company's stock worth $2,468,000 after purchasing an additional 356,867 shares during the last quarter. Finally, First Trust Advisors LP acquired a new position in shares of LifeStance Health Group during the 4th quarter worth about $4,535,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

LFST has been the subject of a number of recent research reports. BTIG Research started coverage on shares of LifeStance Health Group in a report on Friday, July 25th. They issued a "buy" rating and a $8.00 price objective for the company. Wall Street Zen raised shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Finally, UBS Group raised their price target on shares of LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $8.50.

Insider Activity

In other LifeStance Health Group news, Director Darren M. Black sold 8,407,643 shares of the business's stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $42,626,750.01. Following the completion of the transaction, the director directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. The trade was a 20.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ujjwal Ramtekkar sold 16,000 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total value of $95,040.00. Following the sale, the insider owned 113,435 shares in the company, valued at $673,803.90. This trade represents a 12.36% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,423,643 shares of company stock worth $103,561,790. 3.20% of the stock is currently owned by corporate insiders.

LifeStance Health Group Stock Performance

LifeStance Health Group stock remained flat at $5.48 during midday trading on Friday. 2,067,678 shares of the company's stock traded hands, compared to its average volume of 3,217,519. The stock has a market cap of $2.13 billion, a PE ratio of -109.60 and a beta of 1.13. The business has a 50-day moving average price of $4.72 and a 200 day moving average price of $5.92. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. LifeStance Health Group, Inc. has a 52 week low of $3.74 and a 52 week high of $8.61.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02. The firm had revenue of $345.31 million for the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The firm's revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.